Relief Therapeutics Holding Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Michelle Lock
Chief executive officer
CHF 92.5k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | 1.2yrs |
| Board average tenure | 2.9yrs |
Recent management updates
Recent updates
CEO
Michelle Lock (55 yo)
less than a year
Tenure
CHF 92,473
Compensation
Ms. Michelle Lock serves as the Interim Chief Executive Officer and Director since November 22, 2023 at Relief Therapeutics Holding AG and served as its Independent Director from January 28, 2022. She serv...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Interim CEO & Director | less than a year | CHF 92.47k | no data | |
| CFO & Treasurer | 1.2yrs | no data | 0.0028% € 591.3 | |
| Chief Operating Officer | 1.3yrs | CHF 150.00k | 0.62% € 131.0k |
1.2yrs
Average Tenure
55yo
Average Age
Experienced Management: V6M1's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Interim CEO & Director | 2.1yrs | CHF 92.47k | no data | |
| Chairman of the Board | 7.8yrs | CHF 500.00k | no data | |
| Vice-Chairman | 3.2yrs | CHF 150.00k | 0.010% € 2.1k | |
| Independent Director | 2.7yrs | CHF 150.00k | 0.0028% € 587.1 |
2.9yrs
Average Tenure
53.5yo
Average Age
Experienced Board: V6M1's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/02/25 05:17 |
| End of Day Share Price | 2023/11/28 00:00 |
| Earnings | 2023/06/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Relief Therapeutics Holding SA is covered by 2 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Alexandre Müller | Research Dynamics |
| Bob Pooler | ValuationLAB AG |